Nutritional support and management of musculoskeletal diseases

Nutritional Aspects and Clinical Management of Chronic Disorders and Diseases

Volumn , Issue , 2002, Pages 129-154

  Favus, Murray J ^a   Utset, Tammy O ^a   Lee, Chin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85057369587     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Adinoff, A.D. and Hollister, J.R. Steroid-induced fractures and bone loss in patients with asthma. N. Engl. J. Med. 309: 265-268, 1983.
2. American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis. Recommendations for the prevention and treatment of glucocorticoidinduced osteoporosis: 2001 update. (2001) Arth. Rheum. 44: 1496.
3. Argiles, J.M. and Lopez-Soriano, F.J. Catabolic proinflammatory cytokines. Metab. Care. 1: 245-251, 1998.
4. Ball, G.V. and Sorensen, L.B. Pathogenesis of hyperuricemia in saturnine gout. N. Engl. J. Med. 280: 1199-1202, 1969.
5. Bauer, D.C., Browner, W.S., Cauley, J.A., Orwoll, E.S., Scott, J.C., Black, D.M., Tao, J.L., and Cummings, S.R. Factors associated with appendicular bone mass in older women. Ann. Int. Med. 118:657-665, 1993.
6. Becker, M.A. Arthritis and Allied Conditions. Lippincott Williams and Wilkins. Philadelphia, 2001, Chapter 114.
7. Black, D.M., Cummings, S.R., Karpf, D.B., Cauley, J.A., Thompson, D.E., Nevitt, M.C., Bauer, D.C., Genant, H.K., Haskell, W.L., Marcus, R., Ott, S.M., Torner, J.C., Quandt, S.A., Reiss, T.F., and Ensrud, K.E. Randomised trial of effect of alendronate on risk of fractures in women with existing vertebral fractures. Lancet. 348:1535-1541, 1996.
8. Cauley, J.A., Seeley, D.G., Ensrud, K., Ettinger, B., Black, D., and Cummings, S.R. Estrogen replacement therapy and fractures in older women. Ann. Int. Med. 122:9-16, 1995.
9. Chapuy, M.-C. and Meunier, P.J. (1997) Vitamin D insufficiency in adults and the elderly, in Vitamin D. Feldman, D., Glorieux, F.H., and Pike, J.W. (Eds.) Academic Press, San Diego, 1997, Chapter. 43.
10. Coe, F.L., Parks, J.H., Bushinsky, D.A., Langman, C.B., and Favus, M.J. Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int. 33:1140-1146, 1988.
11. Delmas, P.D., Bjarnason, N.H., Mitlak, B.H., Ravoux, A.C., Shah, A.S., Huster, W.J., Draper, M., and Christiansen, C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337:1641-1647, 1997.
12. Dent, C.E. Calcium intake in patients with primary hyperparathyroidism. Lancet 2:330, 1966.
13. Dessein, P.H., Shipton, E.A., Stanwix, A.E., Joffe, B.I., and Ramokgadi, J. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann. Rheum. Dis. 59: 539-543, 2000.
14. Emmerson, B.T. The management of gout. N. Engl. J. Med. 334: 445-551, 1996.
15. Faller, J. and Fox, I.H. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N. Engl. J. Med. 307:1598-1602, 1982.
16. Felson, D.T., Zhang, Y., Anthony, J.M., Naimark, A., and Anderson, J.J. Weight loss reduces the risk for symptomatic knee osteoarthritis in women. Ann. Int. Med. 116:535-539, 1992.
17. Felson, D.T., Lawrence, R.C., Dieppe, P.A., Hirsch, R., Helmick, C.J., Jordan, J.M., Kington, R.S., Lane N.E., Nevitt, M.C., Zhang, Y., Sowers, M., McAlindon, T., Spector, T.D., and Poole, A.R. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann. Int. Med. 133:635-646, 2000.
18. Glorieux, F.H. Hypophosphatemic vitamin D-resistant rickets, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Favus, M.J. (Ed.) Lippincott Williams & Wilkins. Philadelphia, 1996, Chapter 64.
19. Gough, A., Sheeran, T., Bacon, P., and Emery, P. Dietary advice in systemic sclerosis:the dangers of a high fibre diet. Ann. Rheum. Dis. 57: 641-642, 1998.
20. Guedes, C., Dumont-Fischer, D., Leichter-Nakache, S., and Boissier, M.C. Mortality in rheumatoid arthritis. Rev. Rheum. Engl. Ed. 66: 492-498, 1999.
21. Harris, S.T., Watts, N.B., Genant, H.K., McKeever, C.D., Hangartner, T., Keller, M., Chesnut, C.H. 3rd, Brown, J., Eriksen, E.F., Hoseyni, M.S., Axelrod, D.W., and Miller, P.D. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial. JAMA. 282:1344-1352, 1999.
22. Hodgkinson, A. Biochemical aspects of primary hyperparathyroidism: an analysis of 50 cases. Clin. Sci. 25:231, 1963.
23. Holm, I.A., Nelson, A.E., Robinson, B.G., Mason, R.S., Marsh, D.J., Cowell, C.T., and Carpenter, T.O. Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets. J. Clin. Endocrinol. Metab. 86:3889-3899, 2001.
24. Ireland, P. and Fordtran, J.S. Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. J. Clin. Invest. 52:2672-2681, 1973.
25. Johnson, R.J., Kivlighn, S.D., Kim, Y.G., Suga, S., and Fogo, A.B. Reappraisal of the pathogenesis and Consequences of hyperuricemia in hypertension, cardiovascular disease and renal disease. Am. J. Kid. Dis. 33: 225-234, 1999.
26. Kanis, J.A., Melton, L.J. 3rd, Christiansen, C., Johnston, C.C., and Khaltaev, N. The diagnosis of osteoporosis, J. Bone Miner. Res. 8:1137-1141, 1994.
27. Kaplan, R.A., Haussler, M.R., Deftos, L.J., Bone, H., and Pak, C.Y. The role of 1,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J. Clin. Invest. 59:756-760, 1977.
28. Klugman, V.A., Favus, M.J., and Pak, C.Y.C. Nephrolithiasis in primary hyperparathyroidism, in The Parathyroids: Basic and Clinical Concepts. Bilezikian, J.P., Marcus, R., and Levine, M.A. (Eds.) Academic Press, San Diego, 2001, Chapter 27.
29. Liberman, U.A., Weiss, S.R., Broll, J., Minne, H.W., Quan, H., Bell, N.H., Rodriguez-Portales, J., Downs, R.W. Jr., Dequeker, J., and Favus, M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The alendronate phase III osteoporosis treatment study group. N. Engl. J. Med. 333: 14337-1443, 1995.
30. Lips, P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly:consequences for bone loss and fractures and therapeutic implications. Endocrinol. Rev. 22:477-501, 2001.
31. Lukert, B.P. Glucocorticoid-induced osteoporosis, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Favus, M.J., (Ed.) Lippincott Williams & Wilkins, Philadelphia, 1996, Chapter 55.
32. Lundberg, A.C., Akesson, A., and Akesson, B. Dietary intake and nutritional status in patients with systemic sclerosis. Ann. Rheum. Dis. 51:1143-1148, 1992.
33. Mawer, E.B. and Davies, M. Bone disorders associated with gastrointestinal and hepatobiliary disease, in Vitamin D. Feldman, D., Glorieux, F.H., and Pike, J.W. (Eds.) Academic Press, San Diego, 1997, Chapter 51.
34. McAlindon, T.E., Jacques, P., Zhang, Y., Hannan, M.T., Aliabadi, P., Weissman, B., Rush, D., Levy, D., and Felson, D.T. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arth. Rheum. 39: 648-656, 1996.
35. McAlindon, T.E., Felson, D.T., Zhang, Y., Hannan, M.T., Aliabadi, P., Weissman, B., Rush, D., Wilson, P.W.F., and Jacques, P. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann. Int. Med. 125: 353-356, 1996.
36. McAlindon, T. and Felson, D.T. Nutrition: risk factors for osteoarthritis. Ann. Rheum. Dis. 56: 397-400, 1997.
37. McAlindon, T.E., LaValley, M.P., Gulin, J.P., and Felson, D.T. Glucosamine and chondroitin for treatment of osteoarthritis. JAMA. 283: 1469-1475, 2000.
38. McClung, M.R., Geusens, P., Miller, P.D., Zippel, H., Bensen, W.G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., Meunier, P.J., and Reginster, J.Y. (Hip Intervention Program Study Group.) Effect of risedronate on the risk of hip fracture in elderly women. N. Engl. J. Med. 344:333-340, 2001.
39. McGill, N.W. Gout and other crystal-associated arthropathies. Bailliere’s Best Prac. Res. 14: 445-460, 2000.
40. Meacock, S.C.R., Bodmer, J.L., and Billingham, M.E.J. Experimental OA in guinea pigs. J. Exp. Path. 71:279, 1990.
41. Melton, L.J. III, Chrischilles, E.A., Cooper, C., Lane, A.W., and Riggs, B.L. How many women have osteoporosis? J. Bone Miner. Res. 7:1005-1010, 1992.
42. Montrone, F., Fumagalli, M., Sarzi Puttini, P., Boccassini, L., Santandrea, S., Volpato, R., Locati, M., and Caruso, I. Letter: double-blinded study of s-adenosyl-methionine versus placebo in hip and knee arthrosis. Clin. Rheum. 4: 484-485, 1985.
43. National Osteoporosis Foundation. 1996 and 2015: osteoporosis prevalence figures. State-by-state report. Washington, D.C., 1997.
44. Ng, S.C., Clements, P.J., Berquist, W.E., Furst, D.E., and Paulus, H.E. Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease. Arth. Rheum. 32: 212-216, 1989.
45. Pak, C.Y.C., Oata, M., Lawrence, E.C., and Snyder, W. The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J. Clin. Invest. 54: 387-400, 1974.
46. Parfitt, A.M. (1997) Vitamin D and the pathogenesis of rickets and osteomalacia, in Vitamin D. Feldman, D., Glorieux, F.H., and Pike, J.W. (Eds.) Academic Press, San Diego, Chapter 41.
47. Pascual, E., Batlle-Gualda, E., Martinez, A., Rosas, J., and Vela, P. Synovial fluid analysis for diagnosis of intercritical gout. Ann. Int. Med. 131: 756-759, 1999.
48. Pelletier, J.P., Martel-Pelletier, J., and Abramson, S.B. Osteoarthritis, an inflammatory disease: potential implication selection of new therapeutic targets. Arth. Rheum. 44:1237-1247, 2001.
49. Pettifor, J.M. and Daniels, E.D. Vitamin D deficiency and nutritional rickets in children, in Vitamin D. Feldman, D., Glorieux, F.H., and Pike, J.W. (Eds.) Academic Press, San Diego, 1997, Chapter 42.
50. Poirier, T.J. and Rankin, G.B. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases. Am. J. Gastroenterol. 58: 30-44, 1972.
51. Rall, L.C., Rosen, C.J., Dolnikowski, G., Hartman, W.J., Lundgren, N., Abad, L.W., Dinarello, C.A., and Roubenoff, R. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor. Arth. Rheum. 39: 1115-1124, 1996.
52. Rall, C.L. and Roubenoff, R. Encyclopedia of Human Nutrition. Associated Press. San Francisco, 978-982, 1998.
53. Reginster, J.Y., Deroisey, R., Rovati, L.C., Lee, R.L., Lejeune, E., Bruyere, O., Giacovelli, G., Henrotin, Y., Dacre, J.E., and Gossett, C. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet. 357: 251-256, 2001.
54. Reynolds, P.P., Knapp, M.J., Baraf, H.S., and Holmes, E.W. Moonshine and lead. Arth. Rheum. 26: 1057-1064, 1983.
55. Roubenoff, R. Gout and hyperuricemia. Rheum. Dis. Clinics N. Am. 16:539-550, 1990.
56. Roubenoff, R., Roubenoff, R.A., Cannon, J.G., Kehayias, J.J., Zhuang, H., Dawson-Hughes, B., Dinarello, J.G., and Rosenberg, I.H. Rheumatoid cachexia: cytokinedriven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J. Clin. Invest. 93: 2379-2386, 1994.
57. Roubenoff, R., Freeman, L.M., Smith, D.E., Abad, L.W., Dinarello, C.A., and Kehayias, J.J. Adjuvant arthritis as a model of inflammatory cachexia. Arth. Rheum. 40:534-539, 1997.
58. Saag, K.G., Emkey, R., Schnitzer, T.J., Brown, J.P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U.A., Delmas, P.D., Malice, M.P., Czachur, M., and Daifotis, A.G. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N. Engl. J. Med. 339:292-299, 1998.
59. Schwartz, E.R., Leveille, C., and Oh, W.H. Experimentally induced osteoarthritis in guinea pigs: effect of surgical procedure and dietary intake of vitamin C. Lab. Anim. Sci. 31: 683-687, 1981.
60. Sebastian, A.S.T., Harris, S.T., Ottaway, J.H., Todd, K.M., and Morris, R.C. Jr. Improved mineral balance and skeletal metabolism in postmenopausal women treated with potassium bicarbonate. N. Engl. J. Med. 330:1776-1781, 1994.
61. Seibold, J.R. Kelley’s Textbook of Rheumatology. W.B. Saunders Co. St. Louis, 2001, Chapter 83.
62. Sjogren, R.W. Review: gastrointestinal motility disorders in scleroderma. Arth. Rheum. 37:1265-1279, 1994.
63. Stafford-Brady, F.J., Kahn, H.J., Ross, T.M., and Russell, M.L. Advanced scleroderma bowel: complications and management. J. Rheum. 15: 869-874, 1988.
64. Stainforth, J.M., Alison, M.L., and Goodfield, M.J.D. Clinical aspects of the use of gamma linolenic acid in systemic sclerosis. Acta Derm. Venereol. 76: 144-146, 1996.
65. Strong, A.M., Campbell, A., and Thomson, J. The effect of oral linoleic acid and gamma-linolenic acid. Br. J. Clin. Pract. 39:444-445, 1985.
66. Touger-Decker, R. Krauses’s Food, Nutrition and Diet Therapy: Nutritional Care in Rheumatic Diseases. W.B. Saunders Co. Philadelphia, 1996, Chapter 40.
67. Werbach, M.R. Textbook of Nutritional Medicine. Third Line Press, Inc. Tarzana, CA, 1999, 400-402